Microbes May Take Some of the Blame for the Reproducibility Crisis

Scientists find varied microbiota among the same strain of mice from four vendors—and that variability affects their susceptibility to infection.

Written byEmma Yasinski
| 4 min read
black lab mice strain microbiome

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: © ISTOCK.COM, UNOL

For the past several years, science has been plagued by what some consider a reproducibility crisis—the idea that many published studies don’t yield the same results when repeated by other scientists, or sometimes even by the same scientists. Surveys and studies have suggested myriad reasons such as unreliable reagents and cell lines, selective statistics, a bias for publishing studies with positive results, and genetic differences in animal models.

Andreas Bäumler, a microbiologist and immunologist at the University of California, Davis, and his team recently published evidence in Nature Microbiology last month (March 25) that, at least in some mouse studies, the problem may come down to the bacteria in the model’s gut. They found that mice of the same strain but purchased from different vendors had different susceptibilities to infection during experiments, a phenomenon that could be explained by varying microbiomes.

“It’s basically a very well-done ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • emma yasinski

    Emma is a Florida-based freelance journalist and regular contributor for The Scientist. A graduate of Boston University’s Science and Medical Journalism Master’s Degree program, Emma has been covering microbiology, molecular biology, neuroscience, health, and anything else that makes her wonder since 2016. She studied neuroscience in college, but even before causing a few mishaps and explosions in the chemistry lab, she knew she preferred a career in scientific reporting to one in scientific research.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies